Ogilvy CommonHealth Worldwide Looks to the Future

By Ogilvy Commonhealth Worldwide, PRNE
Sunday, January 9, 2011

The World's Largest Healthcare Communications Network Releases Survey Findings, Unveiling Predictions for Healthcare Marketing in 2011

PARSIPPANY, New Jersey, January 10, 2011 - As Ogilvy CommonHealth Worldwide, the largest healthcare communications
network, formally opens its doors for business, the company has released the
results of a global survey of pharmaceutical executives identifying
predictions for healthcare marketing communications in 2011. As might be
expected, the survey revealed a continued shift toward digital
communications, with 74% of respondents anticipating an increased spend on
digital activities in the coming year. Other key survey findings include the
changing role of the patient and a trend toward more customer segmentation.
The survey, which interviewed pharmaceutical executives from 57 countries,
all with responsibilities for marketing or communications, was conducted by
FirstWord Pharma.

"As the world's largest and most extensive healthcare communications
network, we are committed to anticipating changes within the healthcare
industry, and enabling our clients to successfully navigate through a rapidly
evolving healthcare environment," said Matt Giegerich, Chairman and CEO of
Ogilvy CommonHealth Worldwide. "While the survey revealed what we expected it
would about the growing role of digital technologies in healthcare, it is
crucial to remember that technology in itself is not a panacea; it needs to
be adopted and incorporated into our everyday behavior."

Anticipating the role digital communications will continue to have on
healthcare communications, Ogilvy CommonHealth Worldwide has published 202020
VISION, a digital-health report outlining 20 scenarios of what digitally
driven healthcare might look like in 2020.

"In our view, technology, particularly that which has driven social
media, already has had a profound impact on the psychosocial context of
health and healthcare," said David Davenport-Firth, global brand strategy
director and author of 202020 VISION. "And this will continue at an
accelerating pace up to and beyond 2020."

For more information about Ogilvy CommonHealth Worldwide and to
see the results of the global survey of pharmaceutical executives, visit

www.ogilvychww.com.

               To request a copy of 202020 VISION, please contact
                             202020@ogilvy.com.

Notes to Editors:

About the Survey

The survey was conducted by FirstWord Pharma (www.firstwordpharma.com), a
leading supplier of business intelligence solutions for the pharmaceutical
industry, between the dates of December 13, 2010, and December 21, 2010. 264
pharmaceutical executives with responsibilities for marketing or
communications participated in the survey. Survey responses were received
from 57 countries including Argentina, Australia, Austria, Bahrain, Belgium,
Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic,
Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, Guatemala,
Hungary, Ireland, Israel, Italy, Japan, Kenya, Korea, Lebanon, Lithuania,
Macedonia, Malaysia, Mexico, Morocco, Netherlands, Norway, Pakistan, Panama,
Peru, Portugal, Romania, Russia, Saudi Arabia, Slovakia, South Africa, Spain,
Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Turkey, United
Arab Emirates
, United Kingdom, United States, Venezuela and Yugoslavia.

Ogilvy CommonHealth Worldwide

Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a
WPP (NASDAQ: WPPGY, www.wpp.com) company, represents the largest
assembly of creative talent in the world of healthcare communications with
64 offices across 33 countries. Ogilvy CommonHealth Worldwide provides
marketing services including advertising and promotion, brand identity and
development, global integration, direct-to-consumer, direct-to-patient,
relationship marketing, digital/interactive services, managed care
marketing, medical education, media planning and buying, scientific
communications and publications, clinical trial recruitment, market
research and analytics, strategic consulting and public affairs and
relations. The organization houses individual Ogilvy CommonHealth and
Ogilvy Healthworld brand identities in some markets and maintains numerous
partnerships both within and outside the networks of the Ogilvy & Mather
and WPP companies.

WPP

WPP is a world leader in communication services. Through its operating
companies, WPP provides a comprehensive range of advertising and marketing
services including advertising; media investment management; information,
insight and consultancy; public relations and public affairs; branding and
identity; healthcare communications; direct, digital, promotion and
relationship marketing. The company employs 135,000 people (including
associates) in 2,400 offices in 107 countries. For more information, visit
www.wpp.com.

For more information, contact: Beth Paulino, +1-973-352-2278,
bpaulino@commonhealth.com ; Avra Goldstone Lorrimer, +44(0)782-353-3970,
avra.lorrimer@ohpr.com

For more information, contact: Beth Paulino, +1-973-352-2278, bpaulino at commonhealth.com ; Avra Goldstone Lorrimer, +44(0)782-353-3970, avra.lorrimer at ohpr.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :